Zusammenfassung
Die akute respiratorische Insuffizienz [„acute respiratory distress syndrome“ (ARDS)] stellt aufgrund ihrer Komplexität und schlechten Prognose eine enorme intensivmedizinische Herausforderung dar. Trotz aller Fortschritte in Forschung und Therapie bleibt die Letalität unakzeptabel hoch. Ziel des vorliegenden Artikels ist es, Definitionen, klinische Charakteristika und die Pathogenese des ARDS kurz zu skizzieren und auf gegenwärtige Therapieoptionen und zukünftige Entwicklungen in der Behandlung des ARDS einzugehen.
Literatur
Abraham E et al (1999) Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med 27:1478–1485
Abroug F, Ouanes-Besbes L, Dachraoui F et al (2011) An updated study-level meta-analysis of randomised controlled trials on proning in ARDS and acute lung injury. Crit Care 15:R6
ARDS Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342:1301–1308
Ashbaugh DG, Bigelow DB, Petty TL et al (1967) Acute respiratory distress in adults. Lancet 2:319–323
Bernard GR, Artigas A, Brigham KL et al (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
Brower RG, Lanken PN, MacIntyre N et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336
Brun-Buisson C, Minelli C, Bertolini G et al (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30:51–61
Dreyfuss D, Soler P, Basset G et al (1988) High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 137:1159–1164
Felbinger TW, Weigand MA, Mayer K (2012) Supplementation in acute lung injury. JAMA 307:144 (Erwiderung der Autoren: 145-146)
Gao Smith F, Perkins GD, Gates S et al (2012) Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 379:229–235
Goss CH, Brower RG, Hudson LD et al (2003) Incidence of acute lung injury in the United States. Crit Care Med 31:1607–1611
Herridge MS, Cheung AM, Tansey CM et al (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348:683–693
Herridge MS, Tansey CM, Matte A et al (2011) Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 364:1293–1304
Hudson LD, Milberg JA, Anardi D et al (1995) Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293–301
Michael JR, Barton RG, Saffle JR et al (1998) Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 157:1372–1380
Papazian L, Forel JM, Gacouin A et al (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363:1107–1116
Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363
Rice TW, Wheeler AP, Thompson BT et al (2011) Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 306:1574–1581
Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377
Steinberg KP, Hudson LD, Goodman RB et al (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684
Walmrath D, Schneider T, Pilch J et al (1993) Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 342:961–962
Wheeler AP, Bernard GR (2007) Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 369:1553–1564
Wiedemann HP, Wheeler AP, Bernard GR et al (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564–2575
Author information
Authors and Affiliations
Corresponding author
Additional information
Der Originalartikel erschien in: Internist 2012; 53:557–566, Abdruck mit freundlicher Genehmigung der Autoren
Rights and permissions
About this article
Cite this article
Hecker, M., Weigand, M.A. & Mayer, K. Akute respiratorische Insuffizienz. Wien klin Mag 15, 32–37 (2012). https://doi.org/10.1007/s00740-012-0056-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00740-012-0056-5